It's good to see the new bod's claim to better negotiating skills actually bear fruit, especially in relation to integrated products, since we will get a slice of every sale.
True, the ann didn't state or even imply 'higher royalty rates', and so maybe they are not higher, but a similar rate applied to a vastly increased volume is probably satisfactory.
New payment terms are such a relief, the long lag in existing arrangement has been unduly burdensome for OBJ. P&G willingness to respond positively in that respect seems pretty indicative of good will towards OBJ.
- Forums
- ASX - By Stock
- WFL
- Ann: Term Sheet Executed for First Integrated Product
Ann: Term Sheet Executed for First Integrated Product, page-30
-
- There are more pages in this discussion • 40 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add WFL (ASX) to my watchlist
|
|||||
Last
0.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $1.478M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
WFL (ASX) Chart |
Day chart unavailable
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online